Susan T Iannaccone

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Duchenne Muscular Dystrophy

Systemic Sclerosis

Top Venues

Journal of neurology

Advances in therapy

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Susan T Iannaccone, Chunyu Cai, Brittney Rhem, Kaitlin Batley, Veena Rajaram, Benjamin M Greenberg, Sachi Dharia, Craig M Zaidman
Immune-mediated myositis following gene therapy for Duchenne muscular dystrophy: a case report. Journal of neurology (2024)
Susan T Iannaccone, Chunyu Cai, Brittney Rhem, Kaitlin Batley, Veena Rajaram, Benjamin M Greenberg, Sachi Dharia, Craig M Zaidman
Immune-mediated myositis following gene therapy for Duchenne muscular dystrophy: a case report. Journal of neurology 271 (8) (2024)
Susan T Iannaccone, Chunyu Cai, Brittney Rhem, Kaitlin Batley, Veena Rajaram, Benjamin M Greenberg, Sachi Dharia, Craig M Zaidman
Immune-mediated myositis following gene therapy for Duchenne muscular dystrophy: a case report. Journal of neurology 271 (8) (2024)
Susan T Iannaccone, Chunyu Cai, Brittney Rhem, Kaitlin Batley, Veena Rajaram, Benjamin M Greenberg, Sachi Dharia, Craig M Zaidman
Immune-mediated myositis following gene therapy for Duchenne muscular dystrophy: a case report. Journal of neurology 271 (8) (2024)
Susan T Iannaccone, Chunyu Cai, Brittney Rhem, Kaitlin Batley, Veena Rajaram, Benjamin M Greenberg, Sachi Dharia, Craig M Zaidman
Immune-mediated myositis following gene therapy for Duchenne muscular dystrophy: a case report. Journal of neurology 271 (8) (2024)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
Kevin A Strauss, Michelle Anne Farrar, Francesco Muntoni, Kayoko Saito, Jerry R Mendell, Laurent Servais, Hugh J Mcmillan, Richard S Finkel, Kathryn J Swoboda, Jennifer M Kwon, Craig M Zaidman, Claudia A Chiriboga, Susan T Iannaccone, Jena M Krueger, Julie A Parsons, Perry B Shieh, Sarah Kavanagh, Sitra Tauscher-Wisniewski, Bryan E McGill, Thomas A Macek
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial. Nature medicine 28 (7) (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
Kevin A Strauss, Michelle Anne Farrar, Francesco Muntoni, Kayoko Saito, Jerry R Mendell, Laurent Servais, Hugh J Mcmillan, Richard S Finkel, Kathryn J Swoboda, Jennifer M Kwon, Craig M Zaidman, Claudia A Chiriboga, Susan T Iannaccone, Jena M Krueger, Julie A Parsons, Perry B Shieh, Sarah Kavanagh, Melissa Wigderson, Sitra Tauscher-Wisniewski, Bryan E McGill, Thomas A Macek
Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial. Nature medicine 28 (7) (2022)